CAS No. |
2757963-83-8 |
|---|---|
中文名称 |
HCV抑制剂-33 |
英文名称 |
HCV-IN-33 |
别名 |
Benzonitrile, 2-[[4-[(S)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]methyl]-4-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-;HCV-IN-33 |
标准英文名 |
(S)-2-((4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)methyl)-4-(4-methyl-1,4-diazepan-1-yl)benzonitrile |
分子式 |
C31H36ClN5 |
分子量 |
514.12 |
精确分子量 |
513.27 |
SMILES |
N#CC1=CC=C(N2CCN(C)CCC2)C=C1CN3CCN([C@H](C4=CC=C(Cl)C=C4)C5=CC=CC=C5)CC3 |
标准SMILES |
CN1CCCN(CC1)C1C=C(CN2CCN(CC2)[C@@H](C2C=CC=CC=2)C2C=CC(Cl)=CC=2)C(=CC=1)C#N |
用途 |
HCV-IN-33 (Compound (S)-3i) is an HCV entry inhibitor. |
InChIKey |
SMHJTFBKCKZDSO-HKBQPEDESA-N |
|
|
评论 |
|---|